Alfonso Quintas Cardama - Dec 9, 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role
Chief Medical Officer
Signature
/s/ Margaret Siegel as Attorney-in-Fact
Stock symbol
TCRR
Transactions as of
Dec 9, 2022
Transactions value $
-$15,123
Form type
4
Date filed
12/13/2022, 07:26 PM
Previous filing
Dec 9, 2022
Next filing
Dec 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRR Common Stock Sale -$5.04K -4.46K -3.62% $1.13 119K Dec 9, 2022 Direct F1
transaction TCRR Common Stock Sale -$5.04K -4.59K -3.86% $1.10 114K Dec 12, 2022 Direct F1
transaction TCRR Common Stock Sale -$5.04K -4.75K -4.16% $1.06 109K Dec 13, 2022 Direct F1
holding TCRR Common Stock 123K Dec 9, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.